Metabolic Disorder Therapeutics Market
1 Introduction to Research & Analysis Reports
1.1 Metabolic Disorder Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Metabolic Disorder Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Metabolic Disorder Therapeutics Overall Market Size
2.1 Global Metabolic Disorder Therapeutics Market Size: 2021 VS 2028
2.2 Global Metabolic Disorder Therapeutics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Metabolic Disorder Therapeutics Players in Global Market
3.2 Top Global Metabolic Disorder Therapeutics Companies Ranked by Revenue
3.3 Global Metabolic Disorder Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Metabolic Disorder Therapeutics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Metabolic Disorder Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Metabolic Disorder Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Metabolic Disorder Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Metabolic Disorder Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Metabolic Disorder Therapeutics Market Size Markets, 2021 & 2028
4.1.2 Lysosomal Storage Diseases
4.1.3 Diabetes
4.1.4 Obesity
4.1.5 Inherited Metabolic Disorders
4.1.6 Hypercholesterolemia
4.2 By Type - Global Metabolic Disorder Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Metabolic Disorder Therapeutics Revenue, 2017-2022
4.2.2 By Type - Global Metabolic Disorder Therapeutics Revenue, 2023-2028
4.2.3 By Type - Global Metabolic Disorder Therapeutics Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Metabolic Disorder Therapeutics Market Size, 2021 & 2028
5.1.2 Oral
5.1.3 Parenteral
5.1.4 Others
5.2 By Application - Global Metabolic Disorder Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Metabolic Disorder Therapeutics Revenue, 2017-2022
5.2.2 By Application - Global Metabolic Disorder Therapeutics Revenue, 2023-2028
5.2.3 By Application - Global Metabolic Disorder Therapeutics Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Metabolic Disorder Therapeutics Market Size, 2021 & 2028
6.2 By Region - Global Metabolic Disorder Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Metabolic Disorder Therapeutics Revenue, 2017-2022
6.2.2 By Region - Global Metabolic Disorder Therapeutics Revenue, 2023-2028
6.2.3 By Region - Global Metabolic Disorder Therapeutics Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Metabolic Disorder Therapeutics Revenue, 2017-2028
6.3.2 US Metabolic Disorder Therapeutics Market Size, 2017-2028
6.3.3 Canada Metabolic Disorder Therapeutics Market Size, 2017-2028
6.3.4 Mexico Metabolic Disorder Therapeutics Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Metabolic Disorder Therapeutics Revenue, 2017-2028
6.4.2 Germany Metabolic Disorder Therapeutics Market Size, 2017-2028
6.4.3 France Metabolic Disorder Therapeutics Market Size, 2017-2028
6.4.4 U.K. Metabolic Disorder Therapeutics Market Size, 2017-2028
6.4.5 Italy Metabolic Disorder Therapeutics Market Size, 2017-2028
6.4.6 Russia Metabolic Disorder Therapeutics Market Size, 2017-2028
6.4.7 Nordic Countries Metabolic Disorder Therapeutics Market Size, 2017-2028
6.4.8 Benelux Metabolic Disorder Therapeutics Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Metabolic Disorder Therapeutics Revenue, 2017-2028
6.5.2 China Metabolic Disorder Therapeutics Market Size, 2017-2028
6.5.3 Japan Metabolic Disorder Therapeutics Market Size, 2017-2028
6.5.4 South Korea Metabolic Disorder Therapeutics Market Size, 2017-2028
6.5.5 Southeast Asia Metabolic Disorder Therapeutics Market Size, 2017-2028
6.5.6 India Metabolic Disorder Therapeutics Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Metabolic Disorder Therapeutics Revenue, 2017-2028
6.6.2 Brazil Metabolic Disorder Therapeutics Market Size, 2017-2028
6.6.3 Argentina Metabolic Disorder Therapeutics Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Metabolic Disorder Therapeutics Revenue, 2017-2028
6.7.2 Turkey Metabolic Disorder Therapeutics Market Size, 2017-2028
6.7.3 Israel Metabolic Disorder Therapeutics Market Size, 2017-2028
6.7.4 Saudi Arabia Metabolic Disorder Therapeutics Market Size, 2017-2028
6.7.5 UAE Metabolic Disorder Therapeutics Market Size, 2017-2028
7 Players Profiles
7.1 Novo Nordisk A/S
7.1.1 Novo Nordisk A/S Corporate Summary
7.1.2 Novo Nordisk A/S Business Overview
7.1.3 Novo Nordisk A/S Metabolic Disorder Therapeutics Major Product Offerings
7.1.4 Novo Nordisk A/S Metabolic Disorder Therapeutics Revenue in Global Market (2017-2022)
7.1.5 Novo Nordisk A/S Key News
7.2 Sanofi S.A.
7.2.1 Sanofi S.A. Corporate Summary
7.2.2 Sanofi S.A. Business Overview
7.2.3 Sanofi S.A. Metabolic Disorder Therapeutics Major Product Offerings
7.2.4 Sanofi S.A. Metabolic Disorder Therapeutics Revenue in Global Market (2017-2022)
7.2.5 Sanofi S.A. Key News
7.3 Boehringer Ingelheim GmbH
7.3.1 Boehringer Ingelheim GmbH Corporate Summary
7.3.2 Boehringer Ingelheim GmbH Business Overview
7.3.3 Boehringer Ingelheim GmbH Metabolic Disorder Therapeutics Major Product Offerings
7.3.4 Boehringer Ingelheim GmbH Metabolic Disorder Therapeutics Revenue in Global Market (2017-2022)
7.3.5 Boehringer Ingelheim GmbH Key News
7.4 Eli Lilly and Company
7.4.1 Eli Lilly and Company Corporate Summary
7.4.2 Eli Lilly and Company Business Overview
7.4.3 Eli Lilly and Company Metabolic Disorder Therapeutics Major Product Offerings
7.4.4 Eli Lilly and Company Metabolic Disorder Therapeutics Revenue in Global Market (2017-2022)
7.4.5 Eli Lilly and Company Key News
7.5 Merck KgaA
7.5.1 Merck KgaA Corporate Summary
7.5.2 Merck KgaA Business Overview
7.5.3 Merck KgaA Metabolic Disorder Therapeutics Major Product Offerings
7.5.4 Merck KgaA Metabolic Disorder Therapeutics Revenue in Global Market (2017-2022)
7.5.5 Merck KgaA Key News
7.6 Amgen, Inc.
7.6.1 Amgen, Inc. Corporate Summary
7.6.2 Amgen, Inc. Business Overview
7.6.3 Amgen, Inc. Metabolic Disorder Therapeutics Major Product Offerings
7.6.4 Amgen, Inc. Metabolic Disorder Therapeutics Revenue in Global Market (2017-2022)
7.6.5 Amgen, Inc. Key News
7.7 AstraZeneca PLC
7.7.1 AstraZeneca PLC Corporate Summary
7.7.2 AstraZeneca PLC Business Overview
7.7.3 AstraZeneca PLC Metabolic Disorder Therapeutics Major Product Offerings
7.7.4 AstraZeneca PLC Metabolic Disorder Therapeutics Revenue in Global Market (2017-2022)
7.7.5 AstraZeneca PLC Key News
7.8 Actelion Pharmaceuticals Ltd.
7.8.1 Actelion Pharmaceuticals Ltd. Corporate Summary
7.8.2 Actelion Pharmaceuticals Ltd. Business Overview
7.8.3 Actelion Pharmaceuticals Ltd. Metabolic Disorder Therapeutics Major Product Offerings
7.8.4 Actelion Pharmaceuticals Ltd. Metabolic Disorder Therapeutics Revenue in Global Market (2017-2022)
7.8.5 Actelion Pharmaceuticals Ltd. Key News
7.9 Shire PLC
7.9.1 Shire PLC Corporate Summary
7.9.2 Shire PLC Business Overview
7.9.3 Shire PLC Metabolic Disorder Therapeutics Major Product Offerings
7.9.4 Shire PLC Metabolic Disorder Therapeutics Revenue in Global Market (2017-2022)
7.9.5 Shire PLC Key News
7.10 AbbVie, Inc.
7.10.1 AbbVie, Inc. Corporate Summary
7.10.2 AbbVie, Inc. Business Overview
7.10.3 AbbVie, Inc. Metabolic Disorder Therapeutics Major Product Offerings
7.10.4 AbbVie, Inc. Metabolic Disorder Therapeutics Revenue in Global Market (2017-2022)
7.10.5 AbbVie, Inc. Key News
7.11 Biocon Ltd.
7.11.1 Biocon Ltd. Corporate Summary
7.11.2 Biocon Ltd. Business Overview
7.11.3 Biocon Ltd. Metabolic Disorder Therapeutics Major Product Offerings
7.11.4 Biocon Ltd. Metabolic Disorder Therapeutics Revenue in Global Market (2017-2022)
7.11.5 Biocon Ltd. Key News
7.12 BioMarin Pharmaceutical, Inc.
7.12.1 BioMarin Pharmaceutical, Inc. Corporate Summary
7.12.2 BioMarin Pharmaceutical, Inc. Business Overview
7.12.3 BioMarin Pharmaceutical, Inc. Metabolic Disorder Therapeutics Major Product Offerings
7.12.4 BioMarin Pharmaceutical, Inc. Metabolic Disorder Therapeutics Revenue in Global Market (2017-2022)
7.12.5 BioMarin Pharmaceutical, Inc. Key News
7.13 Bristol-Myers Squibb Company
7.13.1 Bristol-Myers Squibb Company Corporate Summary
7.13.2 Bristol-Myers Squibb Company Business Overview
7.13.3 Bristol-Myers Squibb Company Metabolic Disorder Therapeutics Major Product Offerings
7.13.4 Bristol-Myers Squibb Company Metabolic Disorder Therapeutics Revenue in Global Market (2017-2022)
7.13.5 Bristol-Myers Squibb Company Key News
7.14 Cipla, Inc.
7.14.1 Cipla, Inc. Corporate Summary
7.14.2 Cipla, Inc. Business Overview
7.14.3 Cipla, Inc. Metabolic Disorder Therapeutics Major Product Offerings
7.14.4 Cipla, Inc. Metabolic Disorder Therapeutics Revenue in Global Market (2017-2022)
7.14.5 Cipla, Inc. Key News
7.15 CymaBay Therapeutics, Inc.
7.15.1 CymaBay Therapeutics, Inc. Corporate Summary
7.15.2 CymaBay Therapeutics, Inc. Business Overview
7.15.3 CymaBay Therapeutics, Inc. Metabolic Disorder Therapeutics Major Product Offerings
7.15.4 CymaBay Therapeutics, Inc. Metabolic Disorder Therapeutics Revenue in Global Market (2017-2022)
7.15.5 CymaBay Therapeutics, Inc. Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Metabolic Disorder Therapeutics Market Opportunities & Trends in Global Market
Table 2. Metabolic Disorder Therapeutics Market Drivers in Global Market
Table 3. Metabolic Disorder Therapeutics Market Restraints in Global Market
Table 4. Key Players of Metabolic Disorder Therapeutics in Global Market
Table 5. Top Metabolic Disorder Therapeutics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Metabolic Disorder Therapeutics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Metabolic Disorder Therapeutics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Metabolic Disorder Therapeutics Product Type
Table 9. List of Global Tier 1 Metabolic Disorder Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Metabolic Disorder Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Metabolic Disorder Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Metabolic Disorder Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Metabolic Disorder Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Metabolic Disorder Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Metabolic Disorder Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Metabolic Disorder Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Metabolic Disorder Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Metabolic Disorder Therapeutics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Metabolic Disorder Therapeutics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Metabolic Disorder Therapeutics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Metabolic Disorder Therapeutics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Metabolic Disorder Therapeutics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Metabolic Disorder Therapeutics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Metabolic Disorder Therapeutics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Metabolic Disorder Therapeutics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Metabolic Disorder Therapeutics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Metabolic Disorder Therapeutics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Metabolic Disorder Therapeutics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Metabolic Disorder Therapeutics Revenue, (US$, Mn), 2023-2028
Table 30. Novo Nordisk A/S Corporate Summary
Table 31. Novo Nordisk A/S Metabolic Disorder Therapeutics Product Offerings
Table 32. Novo Nordisk A/S Metabolic Disorder Therapeutics Revenue (US$, Mn), (2017-2022)
Table 33. Sanofi S.A. Corporate Summary
Table 34. Sanofi S.A. Metabolic Disorder Therapeutics Product Offerings
Table 35. Sanofi S.A. Metabolic Disorder Therapeutics Revenue (US$, Mn), (2017-2022)
Table 36. Boehringer Ingelheim GmbH Corporate Summary
Table 37. Boehringer Ingelheim GmbH Metabolic Disorder Therapeutics Product Offerings
Table 38. Boehringer Ingelheim GmbH Metabolic Disorder Therapeutics Revenue (US$, Mn), (2017-2022)
Table 39. Eli Lilly and Company Corporate Summary
Table 40. Eli Lilly and Company Metabolic Disorder Therapeutics Product Offerings
Table 41. Eli Lilly and Company Metabolic Disorder Therapeutics Revenue (US$, Mn), (2017-2022)
Table 42. Merck KgaA Corporate Summary
Table 43. Merck KgaA Metabolic Disorder Therapeutics Product Offerings
Table 44. Merck KgaA Metabolic Disorder Therapeutics Revenue (US$, Mn), (2017-2022)
Table 45. Amgen, Inc. Corporate Summary
Table 46. Amgen, Inc. Metabolic Disorder Therapeutics Product Offerings
Table 47. Amgen, Inc. Metabolic Disorder Therapeutics Revenue (US$, Mn), (2017-2022)
Table 48. AstraZeneca PLC Corporate Summary
Table 49. AstraZeneca PLC Metabolic Disorder Therapeutics Product Offerings
Table 50. AstraZeneca PLC Metabolic Disorder Therapeutics Revenue (US$, Mn), (2017-2022)
Table 51. Actelion Pharmaceuticals Ltd. Corporate Summary
Table 52. Actelion Pharmaceuticals Ltd. Metabolic Disorder Therapeutics Product Offerings
Table 53. Actelion Pharmaceuticals Ltd. Metabolic Disorder Therapeutics Revenue (US$, Mn), (2017-2022)
Table 54. Shire PLC Corporate Summary
Table 55. Shire PLC Metabolic Disorder Therapeutics Product Offerings
Table 56. Shire PLC Metabolic Disorder Therapeutics Revenue (US$, Mn), (2017-2022)
Table 57. AbbVie, Inc. Corporate Summary
Table 58. AbbVie, Inc. Metabolic Disorder Therapeutics Product Offerings
Table 59. AbbVie, Inc. Metabolic Disorder Therapeutics Revenue (US$, Mn), (2017-2022)
Table 60. Biocon Ltd. Corporate Summary
Table 61. Biocon Ltd. Metabolic Disorder Therapeutics Product Offerings
Table 62. Biocon Ltd. Metabolic Disorder Therapeutics Revenue (US$, Mn), (2017-2022)
Table 63. BioMarin Pharmaceutical, Inc. Corporate Summary
Table 64. BioMarin Pharmaceutical, Inc. Metabolic Disorder Therapeutics Product Offerings
Table 65. BioMarin Pharmaceutical, Inc. Metabolic Disorder Therapeutics Revenue (US$, Mn), (2017-2022)
Table 66. Bristol-Myers Squibb Company Corporate Summary
Table 67. Bristol-Myers Squibb Company Metabolic Disorder Therapeutics Product Offerings
Table 68. Bristol-Myers Squibb Company Metabolic Disorder Therapeutics Revenue (US$, Mn), (2017-2022)
Table 69. Cipla, Inc. Corporate Summary
Table 70. Cipla, Inc. Metabolic Disorder Therapeutics Product Offerings
Table 71. Cipla, Inc. Metabolic Disorder Therapeutics Revenue (US$, Mn), (2017-2022)
Table 72. CymaBay Therapeutics, Inc. Corporate Summary
Table 73. CymaBay Therapeutics, Inc. Metabolic Disorder Therapeutics Product Offerings
Table 74. CymaBay Therapeutics, Inc. Metabolic Disorder Therapeutics Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Metabolic Disorder Therapeutics Segment by Type in 2021
Figure 2. Metabolic Disorder Therapeutics Segment by Application in 2021
Figure 3. Global Metabolic Disorder Therapeutics Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Metabolic Disorder Therapeutics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Metabolic Disorder Therapeutics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Metabolic Disorder Therapeutics Revenue in 2021
Figure 8. By Type - Global Metabolic Disorder Therapeutics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Metabolic Disorder Therapeutics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Metabolic Disorder Therapeutics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Metabolic Disorder Therapeutics Revenue Market Share, 2017-2028
Figure 12. US Metabolic Disorder Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Metabolic Disorder Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Metabolic Disorder Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Metabolic Disorder Therapeutics Revenue Market Share, 2017-2028
Figure 16. Germany Metabolic Disorder Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 17. France Metabolic Disorder Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Metabolic Disorder Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Metabolic Disorder Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Metabolic Disorder Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Metabolic Disorder Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Metabolic Disorder Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Metabolic Disorder Therapeutics Revenue Market Share, 2017-2028
Figure 24. China Metabolic Disorder Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Metabolic Disorder Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Metabolic Disorder Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Metabolic Disorder Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 28. India Metabolic Disorder Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Metabolic Disorder Therapeutics Revenue Market Share, 2017-2028
Figure 30. Brazil Metabolic Disorder Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Metabolic Disorder Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Metabolic Disorder Therapeutics Revenue Market Share, 2017-2028
Figure 33. Turkey Metabolic Disorder Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Metabolic Disorder Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Metabolic Disorder Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Metabolic Disorder Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 37. Novo Nordisk A/S Metabolic Disorder Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Sanofi S.A. Metabolic Disorder Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Boehringer Ingelheim GmbH Metabolic Disorder Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Eli Lilly and Company Metabolic Disorder Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Merck KgaA Metabolic Disorder Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Amgen, Inc. Metabolic Disorder Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. AstraZeneca PLC Metabolic Disorder Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Actelion Pharmaceuticals Ltd. Metabolic Disorder Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Shire PLC Metabolic Disorder Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. AbbVie, Inc. Metabolic Disorder Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Biocon Ltd. Metabolic Disorder Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. BioMarin Pharmaceutical, Inc. Metabolic Disorder Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Bristol-Myers Squibb Company Metabolic Disorder Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Cipla, Inc. Metabolic Disorder Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. CymaBay Therapeutics, Inc. Metabolic Disorder Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Industry Market Size
